Search

everythinglearnresearchcommunity

for

Search:↓

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Genes and hormones cause hair loss, with four genes contributing equally.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Genetic factors might cause fibrosing alopecia linked to hair shaft abnormalities.

Immune system issues may contribute to female pattern hair loss.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

HGF activator helps convert HGF to its active form, promoting hair growth.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Partially bald areas in Indian AGA patients still have hair growth cells, suggesting early treatment is best.

Higher DHEA-S levels in hirsute females affect hair growth phases.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Dermal papilla cells play a key role in hair loss by responding to androgens.

Hidradenitis suppurativa improves with antiandrogen therapy.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Androgenetic alopecia is common hair loss due to genetics and DHT.

Hair loss risk is influenced by multiple genes.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

Alopecia areata patients have higher hormone levels, suggesting hormonal screening could help in treatment.

58% of men aged 30-50 have hair loss, with severity increasing with age.